Millipore Sigma Vibrant Logo

530799 AGE Inhibitor, LR-90 - CAS 245075-84-7 - Calbiochem

A cell-permeable blocker of advanced glycation end product formation.

AGE Inhibitor, LR-90 - CAS 245075-84-7 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Advanced Glycation Endproducts Inhibitor

Primary Target: =IF(SGM_MetricTransfer!C11=,,SGM_MetricTransfer!C11)
View This Product on Sigma-Aldrich
530799
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
245075-84-7C₃₅H₃₄Cl₂N₄O₈

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.30799.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable methylene bisphenylureido derived compound that blocks the formation of advanced glycation endproduct (AGE) by scavenging dicarbonyl intermediates and by chelating transition metals that catalyze the production of AGE. Inhibits metal ion-catalyzed oxidation of ascorbate (IC50 = 275 µM). Exhibits protective effects against diabetic nephropathy, retinopathy, and atherosclerosis and reduces arterial stiffness in diabetic animals (~50 mg/L drinking water) by reducing collagen accumulation and cross-linking. Although it does not affect glycemic condition and body weight in normal and diabetic animals, it reduces plasma triglycerides and glycated hemoglobin levels in diabetic rats and improves their cardiac output and stroke volume. Also shown to suppress S100b and TNFa-induced activation of NF-κB.

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number530799
      Brand Family Calbiochem®
      SynonymsAdvanced Glycation Endproducts Inhibitor
      References
      ReferencesSatheesan, S., et al. 2014. Br. J. Pharmacol. 171, 3103.
      Nagai, R., et al. 2012. Diabetes. 61, 549.
      Figarola, J.L., et al. 2008. Diabetologia. 51, 882.
      Figarola, J.L., et al. 2003. Diabetologia. 46, 1140.
      Product Information
      CAS number245075-84-7
      FormOff-white powder
      Hill FormulaC₃₅H₃₄Cl₂N₄O₈
      Chemical formulaC₃₅H₃₄Cl₂N₄O₈
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Target=IF(SGM_MetricTransfer!C11=,,SGM_MetricTransfer!C11)
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.30799.0001 04055977242980

      Documentation

      AGE Inhibitor, LR-90 - CAS 245075-84-7 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      参考資料

      参考資料の概要
      Satheesan, S., et al. 2014. Br. J. Pharmacol. 171, 3103.
      Nagai, R., et al. 2012. Diabetes. 61, 549.
      Figarola, J.L., et al. 2008. Diabetologia. 51, 882.
      Figarola, J.L., et al. 2003. Diabetologia. 46, 1140.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-August-2014 JSW
      SynonymsAdvanced Glycation Endproducts Inhibitor
      DescriptionA cell-permeable methylene bisphenylureido derived compound that blocks the formation of advanced glycation endproduct (AGE) by scavenging dicarbonyl intermediates and by chelating transition metals that catalyze the production of AGE. Inhibits metal ion-catalyzed oxidation of ascorbate (IC50 = 275 µM). Exhibits protective effects against diabetic nephropathy, retinopathy, and atherosclerosis and reduces arterial stiffness in diabetic animals (~50 mg/L drinking water) by reducing collagen accumulation and cross-linking. Although it does not affect glycemic condition and body weight in normal and diabetic animals, it reduces plasma triglycerides and glycated hemoglobin levels in diabetic rats and improves their cardiac output and stroke volume. Also shown to suppress S100b and TNFa-induced activation of NF-kB.
      FormOff-white powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number245075-84-7
      Chemical formulaC₃₅H₃₄Cl₂N₄O₈
      Purity≥97% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesSatheesan, S., et al. 2014. Br. J. Pharmacol. 171, 3103.
      Nagai, R., et al. 2012. Diabetes. 61, 549.
      Figarola, J.L., et al. 2008. Diabetologia. 51, 882.
      Figarola, J.L., et al. 2003. Diabetologia. 46, 1140.